A selective, potent, and orally bioavailable CDK7 inhibitor demonstrates superior anti-cancer activity in colorectal cancer models

被引：0
|
作者：
Park, Heuijoon
Seo, Kyoungwan
Yu, Jihyun
Kim, Jieun
Joo, Min Sung
Kim, Sungeun
Lee, Joonhyung
Lee, Jeonghyeon
Kim, Eun-Jung
Nam, Joonwoo
Han, Wooseok
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB168
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB168
引用
收藏
页数：2
相关论文
共 50 条
  • [31] RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models
    Garner, Fiona
    Shomali, Maysoun
    Paquin, Dotty
    Lyttle, C. Richard
    Hattersley, Gary
    ANTI-CANCER DRUGS, 2015, 26 (09) : 948 - 956
  • [32] A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties
    Pitman, Melissa R.
    Powell, Jason A.
    Coolen, Carl
    Moretti, Paul A. B.
    Zebol, Julia R.
    Pham, Duyen H.
    Finnie, John W.
    Don, Anthony S.
    Ebert, Lisa M.
    Bonder, Claudine S.
    Gliddon, Briony L.
    Pitson, Stuart M.
    ONCOTARGET, 2015, 6 (09) : 7065 - 7083
  • [33] Biochemical, Cellular, and Anti-Inflammatory Properties of a Potent, Selective, Orally Bioavailable Benzamide Inhibitor of Rho Kinase Activity
    Rajagopalan, Lakshman E.
    Davies, Michael S.
    Kahn, Larry E.
    Kornmeier, Christine M.
    Shimada, Hideaki
    Steiner, Toni A.
    Zweifel, Ben S.
    Wendling, Jay M.
    Payne, Maria A.
    Loeffler, Richard F.
    Case, Brenda L.
    Norton, Monica B.
    Parikh, Mihir D.
    Nemirovskiy, Olga V.
    Mourey, Robert J.
    Masferrer, Jaime L.
    Misko, Thomas P.
    Kolodziej, Stephen A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (03): : 707 - 716
  • [34] Defining modulators of response to samuraciclib, a CDK7 inhibitor for breast cancer
    Jurgaityte, Kaste
    Sava, Georgina
    Lai, Chun Fui
    Fan, Hailing
    Nguyen, Van
    Buluwela, Laki
    Ali, Simak
    CANCER RESEARCH, 2023, 83 (07)
  • [35] TAS-116, a Novel, Orally Bioavailable HSP90a/β Selective Inhibitor Demonstrates Highly Potent Antitumor Activity in Preclinical Models with a Favorable PK Profile
    Ohkubo, S.
    Muraoka, H.
    Hashimoto, A.
    Ito, S.
    Ito, K.
    Shibata, Y.
    Kanoh, A.
    Kitade, M.
    Yonekura, K.
    Utsugi, T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 89 - 89
  • [36] Targeting CDK7 increases the stability of Snail to promote the dissemination of colorectal cancer
    Yan Zhou
    Linlin Lu
    Guanmin Jiang
    Zhuojia Chen
    Jiexin Li
    Panpan An
    Likun Chen
    Jun Du
    Hongsheng Wang
    Cell Death & Differentiation, 2019, 26 : 1442 - 1452
  • [37] Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation
    Yu, Mingfeng
    Long, Yi
    Yang, Yuchao
    Li, Manjun
    Teo, Theodosia
    Noll, Benjamin
    Philip, Stephen
    Wang, Shudong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 218
  • [38] Discovery of potent and selective EP300 degraders with anti-cancer activity
    Zimmerman, Mark
    Sappal, Darshan
    Adam, Ammar
    Adams, Benjamin
    Adhikari, Ketaki
    Austin, Wesley
    Bullock, Breanna
    DiBernardo, Julie
    Dixon, Thomas
    Elliot, GiNell
    Ethell, Brian
    Gervais, Anais
    Hossain, Md Imran
    Huang, David
    Lahr, Dave
    Lin, Mei Yun
    Mayhew, David
    Mizeracka, Karolina
    Negretti, Solymar
    Nguyen, Tyler
    Prifti, Olga
    Schiller, Shawn
    Sherbanee, Brenna
    Terry, David
    Ucisik, Nihan
    Wittenborn, Elizabeth
    LaBonte, Laura
    Daniels, Danette
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [39] Discovery of potent and selective EP300 degraders with anti-cancer activity
    Zimmerman, Mark
    Adam, Ammar
    Ahmad, Hafiz
    Adams, Benjamin
    Adhikari, Ketaki
    Austin, Wesley
    Bullock, Breanna
    Di Bernardo, Julie
    Dixon, Thomas
    Daniels, Danette
    Dominici, Claudia
    Elliot, GiNell
    Ethell, Brian
    Gervais, Anais
    Hossain, Md Imran
    Huang, David
    Lahr, Dave
    Lin, Mei Yun
    Mayhew, David
    Mizeracka, Karolina
    Negretti, Solymar
    Nguyen, Tyler
    Prifti, Olga
    Sappal, Darshan
    Schiller, Shawn
    Sherbanee, Brenna
    Terry, David
    Ucisik, Nihan
    Wittenborn, Elizabeth
    Zhou, Qianhe
    La Bonte, Laura
    CANCER RESEARCH, 2024, 84 (06)
  • [40] Targeting CDK7 increases the stability of Snail to promote the dissemination of colorectal cancer
    Zhou, Yan
    Lu, Linlin
    Jiang, Guanmin
    Chen, Zhuojia
    Li, Jiexin
    An, Panpan
    Chen, Likun
    Du, Jun
    Wang, Hongsheng
    CELL DEATH AND DIFFERENTIATION, 2019, 26 (08): : 1442 - 1452
12345